Clinical Trial Update: A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase II study evaluating an all-oral combination of low-dose etoposide and capecitabine in metastatic br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Etoposide (Etoposide)

Snippet

Sponsor: Tao OUYANG | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED